HIMS benefits from strong online revenue, subscriber growth, and global expansion moves to fuel its health platform momentum. However, challenges may hurt performance.

National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

In a busy week that includes much-anticipated quarterly reports, a pair of standouts among the finance and aerospace sectors ...

Indian retail investors ramped up US stock purchases amid global market volatility, with a strong tilt toward semiconductors, ...

Detailed price information for Paypal Holdings (PYPL-Q) from The Globe and Mail including charting and trades.

Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.

Steel Dynamics (STLD) ended the recent trading session at $131.15, demonstrating a +2.89% change from the preceding day's ...

RTX Corp. RTX is slated to release second-quarter 2025 results on July 22, before the opening bell.

Executives and directors of Hims & Hers Health Inc., a leading telehealth company, are facing a shareholder derivative ...

A record flood of new cash. Leveraged and inverse products. Hedge-fund and private-equity firms getting in. Exchange-traded ...

Novo Nordisk (NVO) closed the most recent trading day at $65.29, moving 2.61% from the previous trading session.